Image Guided Biodistribution and Pharmacokinetic Studies of Theranostics

Image guided technique is playing an increasingly important role in the investigation of the biodistribution and pharmacokinetics of drugs or drug delivery systems in various diseases, especially cancers. Besides anatomical imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), molecular imaging strategy including optical imaging, positron emission tomography (PET) and single-photon emission computed tomography (SPECT) will facilitate the localization and quantization of radioisotope or optical probe labeled nanoparticle delivery systems in the category of theranostics. The quantitative measurement of the bio-distribution and pharmacokinetics of theranostics in the fields of new drug/probe development, diagnosis and treatment process monitoring as well as tracking the brain-blood-barrier (BBB) breaking through by high sensitive imaging method, and the applications of the representative imaging modalities are summarized in this review.

[1]  R. Kimura,et al.  PET Imaging of Integrin Positive Tumors Using 18F Labeled Knottin Peptides , 2011, Theranostics.

[2]  Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice. , 2008, Cancer biotherapy & radiopharmaceuticals.

[3]  Hong Ding,et al.  Tumor targeting and imaging in live animals with functionalized semiconductor quantum rods. , 2009, ACS applied materials & interfaces.

[4]  James H Thrall,et al.  Using imaging biomarkers to accelerate drug development and clinical trials. , 2005, Drug discovery today.

[5]  R. Ivkov,et al.  NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. , 2008, Bioconjugate chemistry.

[6]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[7]  J. Katz,et al.  Taxotere Chemosensitivity Evaluation in Mice Prostate Tumor: Validation and Diagnostic Accuracy of Quantitative Measurement of Tumor Characteristics by MRI, PET, and Histology of Mice Tumor , 2008, Technology in cancer research & treatment.

[8]  David W Townsend,et al.  PET/CT today and tomorrow. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  W. Pardridge,et al.  Humanization of anti‐human insulin receptor antibody for drug targeting across the human blood–brain barrier , 2007, Biotechnology and bioengineering.

[10]  Hong Ding,et al.  Optically and Magnetically Doped Organically Modified Silica Nanoparticles as Efficient Magnetically Guided Biomarkers for Two-Photon Imaging of Live Cancer Cells† , 2008 .

[11]  Scott C Davis,et al.  Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications. , 2010, Journal of photochemistry and photobiology. B, Biology.

[12]  Yi Wang,et al.  Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. , 2010, Bioconjugate chemistry.

[13]  Hong Ding,et al.  Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles. , 2010, Current HIV research.

[14]  Yin Zhang,et al.  Positron emission tomography imaging of CD105 expression during tumor angiogenesis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  A. Scott,et al.  Phase I Biodistribution and Pharmacokinetic Study of Lewis Y–Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers , 2009, Clinical Cancer Research.

[16]  L. Adler,et al.  Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  F. Erogbogbo,et al.  Multimodal imaging probes based on Gd-DOTA conjugated quantum dot nanomicelles. , 2011, The Analyst.

[18]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[19]  R. Boellaard,et al.  Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients , 2006, Clinical Cancer Research.

[20]  William D Rooney,et al.  Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  K. Kubota,et al.  Clinical Role of FDG PET/CT for Methotrexate-Related Malignant Lymphoma , 2011, Clinical nuclear medicine.

[22]  I. Mora‐Seró,et al.  Imaging of resonant quenching of surface plasmons by quantum dots. , 2006, Nano letters.

[23]  S R Cherry,et al.  A microPET/CT system for in vivo small animal imaging. , 2007, Physics in medicine and biology.

[24]  J. Hoppin,et al.  JPET Miniseries : Imaging Assessing Antibody Pharmacokinetics in Mice with In Vivo Imaging , 2011 .

[25]  W. Heiss,et al.  The potential of PET/MR for brain imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  H. Hollema,et al.  In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft , 2007, Journal of Nuclear Medicine.

[27]  J. Borlak,et al.  Combined microPET/CT for imaging of hepatocellular carcinoma in mice. , 2009, Frontiers in bioscience.

[28]  S. Treves,et al.  Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. , 2011, Nuclear medicine and biology.

[29]  Hong Ding,et al.  Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers , 2011, Nanotechnology.

[30]  B. Engelhardt,et al.  Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.

[31]  J. Baars,et al.  CD20 antigen imaging with 124I-rituximab PET/CT in patients with rheumatoid arthritis , 2011 .

[32]  M. Breunig,et al.  Quantum dots - nano-sized probes for the exploration of cellular and intracellular targeting. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  J. Capala,et al.  Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer , 2009, Current opinion in oncology.

[34]  Roger Y. Tsien,et al.  Improved green fluorescence , 1995, Nature.

[35]  M. Robinson,et al.  Immuno-positron emission tomography in cancer models. , 2010, Seminars in nuclear medicine.

[36]  R. Ivkov,et al.  Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy , 2005, Clinical Cancer Research.

[37]  Linda Knutsson,et al.  99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes , 2012, The Journal of Nuclear Medicine.

[38]  U. Häfeli,et al.  Evaluation of (111)In labeled antibodies for SPECT imaging of mesothelin expressing tumors. , 2011, Nuclear medicine and biology.

[39]  Tara Heitner,et al.  In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice , 2009, Journal of Nuclear Medicine.

[40]  Tayyaba Hasan,et al.  Development and applications of photo-triggered theranostic agents. , 2010, Advanced drug delivery reviews.

[41]  Hao Hong,et al.  In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. , 2012, Biomaterials.

[42]  Zhen Cheng,et al.  Proof-of-Concept Study of Monitoring Cancer Drug Therapy with Cerenkov Luminescence Imaging , 2012, The Journal of Nuclear Medicine.

[43]  Dale O. Kiesewetter,et al.  PET imaging of CXCR4 using copper-64 labeled peptide antagonist , 2011, Theranostics.

[44]  M. Lubberink,et al.  Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[45]  Marilyn E. Morris,et al.  Pharmacokinetics, Lymph Node Uptake, and Mechanistic PK Model of Near-Infrared Dye-Labeled Bevacizumab After IV and SC Administration in Mice , 2012, The AAPS Journal.

[46]  H. Hanaoka,et al.  Dual functional molecular imaging probe targeting CD20 with PET and optical imaging. , 2009, Oncology Report.

[47]  C. McCulloch,et al.  Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. , 2007, AJR. American journal of roentgenology.

[48]  G. V. van Dongen,et al.  Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets , 2011, EJNMMI research.

[49]  Kazuhiro Mino,et al.  In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dye , 2009, Proceedings of the National Academy of Sciences.

[50]  D. Yee,et al.  Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. , 2008, Nanomedicine.

[51]  Hong Ding,et al.  Bioconjugation of luminescent silicon quantum dots for selective uptake by cancer cells. , 2011, Bioconjugate chemistry.

[52]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[53]  S. Park,et al.  Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis , 2012, European Radiology.

[54]  K. S. Rao,et al.  DNA double strand break repair in brain: Reduced NHEJ activity in aging rat neurons , 2006, Neuroscience Letters.

[55]  F. Erogbogbo,et al.  Non-invasive tumor detection in small animals using novel functional Pluronic nanomicelles conjugated with anti-mesothelin antibody. , 2011, Nanoscale.

[56]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[57]  Hong Ding,et al.  Simple high-performance liquid chromatographic method for the determination of tetramethylpyrazine phosphate in very small volumes of dog plasma: application to a pharmacokinetic study. , 2006, Journal of chromatographic science.

[58]  W. Banks.  Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. , 1999, Journal of neurovirology.

[59]  R. Weissleder.  Scaling down imaging: molecular mapping of cancer in mice , 2002, Nature Reviews Cancer.

[60]  Hong Ding,et al.  Biocompatible magnetofluorescent probes: luminescent silicon quantum dots coupled with superparamagnetic iron(III) oxide. , 2010, ACS nano.

[61]  R. Kumar,et al.  Noninvasive real-time fluorescence imaging of the lymphatic uptake of BSA-IRDye 680 conjugate administered subcutaneously in mice. , 2012, Journal of pharmaceutical sciences.

[62]  Morand Piert,et al.  Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[63]  P. Choyke,et al.  PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. , 2011, Seminars in nuclear medicine.

[64]  George Sgouros,et al.  Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[65]  M. Morris,et al.  5,7-Dimethoxyflavone and Multiple Flavonoids in Combination Alter the ABCG2-Mediated Tissue Distribution of Mitoxantrone in Mice , 2011, Pharmaceutical Research.

[66]  S. Gambhir.  Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[67]  Mingyuan Gao,et al.  Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. , 2012, ACS nano.

[68]  Adela C. Bonoiu,et al.  Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication , 2010, Proceedings of the National Academy of Sciences.

[69]  E. Moriyama,et al.  Optical Molecular Imaging: From Single Cell to Patient , 2008, Clinical pharmacology and therapy.

[70]  Andreas Kjær,et al.  Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[71]  Sophie Lancelot,et al.  Small-animal positron emission tomography as a tool for neuropharmacology. , 2010, Trends in pharmacological sciences.

[72]  K. Scearce-Levie,et al.  A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo , 2011, Science Translational Medicine.

[73]  Hong Ding,et al.  Synthesis and characterization of temperature-responsive copolymer of PELGA modified poly(N-isopropylacrylamide) , 2006 .

[74]  Hong Ding,et al.  Gold nanorod--siRNA induces efficient in vivo gene silencing in the rat hippocampus. , 2011, Nanomedicine.

[75]  W. Luk,et al.  Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target , 2011, Science Translational Medicine.

[76]  Kai Chen,et al.  PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.

[77]  W Cai,et al.  Molecular imaging with nucleic acid aptamers. , 2011, Current medicinal chemistry.

[78]  Hong Ding,et al.  In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals. , 2011, ACS nano.

[79]  W Wang,et al.  Monoclonal Antibody Pharmacokinetics and Pharmacodynamics , 2008, Clinical pharmacology and therapeutics.

[80]  Hong Ding,et al.  Gold Nanorods Coated with Multilayer Polyelectrolyte as Contrast Agents for Multimodal Imaging , 2007 .

[81]  A. Bockisch,et al.  Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[82]  S. Harris,et al.  OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice , 2012, Journal of Lipid Research.

[83]  M. Morris,et al.  Fluorescence Imaging of the Lymph Node Uptake of Proteins in Mice after Subcutaneous Injection: Molecular Weight Dependence , 2012, Pharmaceutical Research.

[84]  Woo Kyung Moon,et al.  Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors , 2012, Theranostics.

[85]  R. Prassl,et al.  Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals , 2010, Journal of liposome research.

[86]  C. Dullin,et al.  Tumor localization of an anti-TGF-β antibody and its effects on gliomas. , 2010, International journal of oncology.

[87]  S. Treves,et al.  Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates , 2007, Proceedings of the National Academy of Sciences.

[88]  T. Smith,et al.  Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging. , 2010, The British journal of radiology.

[89]  Hong Ding,et al.  Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging , 2010, Nanotechnology.

[90]  W. Law,et al.  Aqueous-phase synthesis of highly luminescent CdTe/ZnTe core/shell quantum dots optimized for targeted bioimaging. , 2009, Small.

[91]  M Wintermark,et al.  Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment , 2007, Neurology.

[92]  E. Martin,et al.  Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. , 2009, Molecular pharmaceutics.

[93]  B. Hyman,et al.  Nanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging , 2011, Proceedings of the National Academy of Sciences.

[94]  M. Azadniv,et al.  Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses. , 2009, Molecular pharmaceutics.

[95]  M. Marzola,et al.  Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. , 2010, European journal of radiology.

[96]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[97]  Bernhard Schölkopf,et al.  MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration , 2008, Journal of Nuclear Medicine.

[98]  Andrew V. Sutherland,et al.  Molecular tracers for the PET and SPECT imaging of disease. , 2011, Chemical Society reviews.

[99]  Hong Ding,et al.  Imaging pancreatic cancer using bioconjugated InP quantum dots. , 2009, ACS nano.

[100]  Thomas K. Lewellen,et al.  Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors , 2005, SPIE Medical Imaging.

[101]  H. Hanaoka,et al.  Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu‐labeled bevacizumab in colorectal cancer xenografts , 2011, Cancer science.

[102]  K. Suga,et al.  F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas. , 2009, Clinical nuclear medicine.

[103]  Adela C. Bonoiu,et al.  Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons , 2009, Proceedings of the National Academy of Sciences.

[104]  R. Mumper,et al.  In Situ Blood–Brain Barrier Transport of Nanoparticles , 2003, Pharmaceutical Research.

[105]  A. De,et al.  Reporter Gene Imaging in Therapy and Diagnosis , 2012, Theranostics.